| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $52.6B | $56.2B | $49.7B | $58.2B | $40.8B | $27.2B | $8.0B | $9.2B |
| Cost of Revenue | $38.6B | $42.6B | $37.0B | $45.8B | $29.9B | $16.7B | $22.1B | $26.8B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $7.3B | $7.3B | $6.9B | $6.9B | $6.1B | $5.0B | $1.4B | $1.6B |
| Net Income | $5.8B | $5.9B | $5.5B | $5.5B | $4.6B | $3.8B | $1.1B | $1.3B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $77.9B | $77.2B | $71.0B | $68.1B | $67.5B | $64.1B | $61.7B | $57.0B |
| Current Assets | $13.4B | $15.1B | $12.2B | $10.6B | $13.3B | $9.9B | $7.9B | $6.1B |
| Cash & Equivalents | $1.0B | $0.6B | $0.2B | $0.1B | $2.8B | $1.1B | $0.3B | $0.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $12.8B | $15.2B | $13.1B | $12.3B | $11.6B | $9.0B | $9.1B | $7.2B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.6B | $8.1B | $7.6B | $8.0B | $8.5B | $5.9B | $6.5B | $6.1B |
| Investing Cash Flow | $-5.5B | $-5.4B | $-3.2B | $-5.0B | $-2.1B | $-3.1B | $-4.6B | $-4.3B |
| Capital Expenditures | — | $4.5B | $3.3B | $2.0B | $2.2B | $3.3B | $4.5B | $4.2B |
| Financing Cash Flow | $-2.7B | $-2.2B | $-4.3B | $-5.8B | $-4.6B | $-2.0B | $-1.9B | $-1.5B |